Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis
Summary
The new solution is a direct result of a co-development collaboration between Parse Biosciences and DNAnexus, the leading provider of cloud-based genomic and biomedical data access and companion analysis software. The Parse Biosciences platform is built on top of the proven DNAnexus technology, which allows researchers to access, analyze, and share scRNA-seq data to help advance scientific discovery. “We are thrilled to announce this cloud analysis software, making our single cell solution even easier to adopt,” said Alex Rosenberg, CEO of Parse Biosciences. CTO and co-founder Charlie Roco will present on the new analysis solution along with the Evercode WT v2 chemistry at his CoLab session titled “Democratizing Access to Single Cell RNA Sequencing,” on Wednesday, October 26 at 3:45 PM in Theater 1. Single-cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.